-transparent.png){kind=logo}
Prognostic factors have been re-evaluated for 88 patients with Stage III Hodgkin's disease to see if they have remained significant on a long-term basis. Treatment had consisted of two cycles of MOPP followed by radiotherapy to the mantle, abdomen, and pelvis; all patients had achieved complete remission. Case material was grouped according to the presence of absence of mediastinal disease. Five-year survivals for Stage IIIA and IIIB patients were 85 and 80%; corresponding disease-free survivals were 76 and 73%. Significant prognostic factors include age, histopathology, and extent of abdominal disease, but the relative importance of these factors differs for the mediastinal and nonmediastinal patients. Modifications of current treatment policy for both mediastinal and nonmediastinal patients are discussed in relation to the prognostic factors.
R W Rodgers, and
L M Fuller, and
F B Hagemeister, and
D A Johnston, and
J A Sullivan, and
L B North, and
J J Butler, and
W S Velasquez, and
F G Conrad, and
C C Shullenberger
January 1989,
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
R W Rodgers, and
L M Fuller, and
F B Hagemeister, and
D A Johnston, and
J A Sullivan, and
L B North, and
J J Butler, and
W S Velasquez, and
F G Conrad, and
C C Shullenberger
January 1991,
Annals of oncology : official journal of the European Society for Medical Oncology,
R W Rodgers, and
L M Fuller, and
F B Hagemeister, and
D A Johnston, and
J A Sullivan, and
L B North, and
J J Butler, and
W S Velasquez, and
F G Conrad, and
C C Shullenberger
February 1985,
Cancer,
R W Rodgers, and
L M Fuller, and
F B Hagemeister, and
D A Johnston, and
J A Sullivan, and
L B North, and
J J Butler, and
W S Velasquez, and
F G Conrad, and
C C Shullenberger
September 1980,
Cancer,
R W Rodgers, and
L M Fuller, and
F B Hagemeister, and
D A Johnston, and
J A Sullivan, and
L B North, and
J J Butler, and
W S Velasquez, and
F G Conrad, and
C C Shullenberger
July 1987,
International journal of radiation oncology, biology, physics,
R W Rodgers, and
L M Fuller, and
F B Hagemeister, and
D A Johnston, and
J A Sullivan, and
L B North, and
J J Butler, and
W S Velasquez, and
F G Conrad, and
C C Shullenberger
May 1985,
Medicina clinica,
R W Rodgers, and
L M Fuller, and
F B Hagemeister, and
D A Johnston, and
J A Sullivan, and
L B North, and
J J Butler, and
W S Velasquez, and
F G Conrad, and
C C Shullenberger
August 1988,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
R W Rodgers, and
L M Fuller, and
F B Hagemeister, and
D A Johnston, and
J A Sullivan, and
L B North, and
J J Butler, and
W S Velasquez, and
F G Conrad, and
C C Shullenberger
November 1983,
Cancer,
R W Rodgers, and
L M Fuller, and
F B Hagemeister, and
D A Johnston, and
J A Sullivan, and
L B North, and
J J Butler, and
W S Velasquez, and
F G Conrad, and
C C Shullenberger
July 1973,
Cancer,
R W Rodgers, and
L M Fuller, and
F B Hagemeister, and
D A Johnston, and
J A Sullivan, and
L B North, and
J J Butler, and
W S Velasquez, and
F G Conrad, and
C C Shullenberger
January 1978,
International journal of radiation oncology, biology, physics,
